Filing Flows › Biomerica (BMRA) › Q4 FY26 › vs Q4 FY25
Biomerica (BMRA) Q4 FY26 vs Q4 FY25 (year over year)
Biomerica's revenue rose $126K (+17%) from $749K in Q4 FY25 to $875K in Q4 FY26.
Biomerica, Q4 FY26: revenue $875K (+17% year over year), operating margin -175.2%, net loss $1.1M, operating cash flow −$912K. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q4 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $875K | $749K | $126K | +17% |
| Other income, net | $394K | $25K | $369K | 16× |
| Net loss | $1.1M | $1.5M | −$399K | -26% |
| Costs & expenses | $2.4M | $2.3M | $96K | +4% |
| Operating costs | $2.4M | $2.3M | $95K | +4% |
| Income tax | $6K | $5K | $1K | +20% |
| Cost of revenue | $946K | $993K | −$47K | -5% |
| Research & development | $205K | $252K | −$47K | -19% |
| Sales & marketing | $381K | $376K | $5K | +1% |
| General & admin | $876K | $692K | $184K | +27% |
| Operating cash sources | $1.1M | $1.5M | −$399K | -26% |
| Depreciation & amortization | $17K | $23K | −$6K | -26% |
| Share-based compensation | $91K | $108K | −$17K | -16% |
| Working capital & other | $125K | $751K | −$626K | -83% |
| Cash used in operations | $912K | $662K | $250K | +38% |
| Net loss absorbed | $1.1M | $1.5M | −$399K | -26% |
Questions
How much did Biomerica's revenue grow year over year in Q4 FY26?
Biomerica's revenue rose $126K (+17%) from $749K in Q4 FY25 to $875K in Q4 FY26.